|
Quality of Life for Allergy Patients
|
Ocular allergy is a common condition presenting a major source of frustration and discomfort, yet the effects of this non-sight-threatening chronic disease are often overlooked. It's important to recognize the increasing prevalence of ocular allergies as well as their impact on patient quality of life. Various surveys and questionnaires have been developed to assess the impact of ocular allergic symptoms in affecting patients' quality of life.1, 2,3,4,5,6 ynese validated studies have all demo...
Related newspaper, magazine, and journal articles from HighBeam Research
|
|
Quality of Life for Allergy Patients
Ophthalmology Times
; Ocular allergy is a common condition presenting a major source of frustration and discomfort, yet the effects of this non-sight-threatening chronic disease are often overlooked. It's important to recognize the increasing prevalence of ocular allergies as well as their impact on patient quality of
|
|
|
NEW TREATMENTS IN OCULAR ALLERGY
Ophthalmology Times
; The current pharmacopoeia oftopical treatments for ocular allergy comprises agents with antihistaminic and/or decongestant effects, mast-cell stabilizers, compounds with both antihistaminic and mast-cell stabilizing activity, and ariti-inflammatory/immunomodulatory drugs, either corticosteroids or
|
|
|
Potent, safe allergic conjunctivitis treatment available OTC
Ophthalmology Times
; Treating signs/symptoms Antihistamine/mast cell stabilizer lasts up to 12 hours without risk of rebound redness Reviewed by Marguerite B. McDonald, MD Lynbrook, NY-Ketotiten fumarate ophthalmic solution 0.025% (Zaditor, Novartis) offers potcnl, fast-acting treatment tor the signs and symptoms of
|
|
|
Allergy drug has multiple mechanisms of action
Ophthalmology Times
; Another choice Ketotifen fumarate solution targets mast cells, eosinophils to provide relief Reviewed by Penny A. Asbell, MD, FACS, MBA New York-As one of the category of ocular allergy drugs that target several substances in the allergic cascade, ketotifen fumarate ophthalmic solution, 0.025%
|
|
|
Nedocromil sodium 2% an ideal option for managing chronic ocular allergy
Ophthalmology Times
; Second-generation agent Nedocrornil sodium 2% an ideal option for managing chronic ocular allergy Solution's efficacy improves with increasing duration of use, maintained over long term Reviewed by Eric D. Donnenfeld, MD Rockville Center, NV-Nedocromil sodium 2% ophthalmic solution (Alocril,
|
|
New formulations: Vigamox
Formulary
; Moxifloxacin ophthalmic solution, 0.5% ALCON Broad-spectrum antibiotic available as ophthalmic solution The high solubility of moxifloxacin allows it to be formulated to a higher concentration ophthalmic solution (0.5%) than other 4th generation fluoroquinolones. Because of the inherent
|
|
|
Quality of life improves in patients with allergic conjunctivitis
Ophthalmology Times
; General Seasonal allergy Itching, watery eyes, swelling greatly diminished after treatment with nedocromil sodium Kansas City, MO-Nedocromil sodium 2% ophthalmic solution (Alocril, Allergan, Irvine, CA) for the treatment of allergic conjunctivitis significantly improves patients' quality of life,
|
|
|
Reformulation provides IOP control more safely
Ophthalmology Times
; Fewer side effects Brimonidine tartrate solution stabilized with Purite reduces likelihood of ocular allergy Austin, TX-Brimonidine-Purite 0.15% (Alphagan P, Allergan), a new formulation of brimonidine tartrate ophthalmic solution in which benzalkonium chloride has been replaced with Purite, offers
|
|
|
Mast cell stabilizer recommended for chronic ocular allergy
Ophthalmology Times
; Second-generation agent Long duration of action advantageous for patients with dry eye, contact lenses Reviewed by Jodi Luchs, MD Wantagh, NY-Because of its ability to halt the allergic cascade, its long duration of action, and rapid relief of itching, nedocromil sodium ophthalmic solution 2%
|
|
Pemirolast for Allergic Conjunctivitis.
American Family Physician
; The U.S. Food and Drug Administration (FDA) has approved pemirolast potassium (Alamast) ophthalmic solution 0.1 percent, a new ocular allergy medication indicated for the prevention of itching associated with allergic conjunctivitis. Approximately 20 percent of persons in the United States have
|